You can deliver the same weekly total in different ways—once weekly, twice weekly, every other day (EOD), or daily—to control peak–trough swings. If you come across forum phrases like "test propionate dosage per week," remember that medical dosing should still be personalized and safety-monitored as described by the Endocrine Society. Enanthate behaves similarly to cypionate—clinics often use comparable weekly or twice-weekly schedules and titrate based on labs and symptoms. Cypionate is widely used because its ester length supports once- or twice-weekly dosing with relatively predictable levels.
Testosterone is a hormone that your sex organs mainly produce. It’s like my body goes into fight-or-flight mode — nervous energy, inner tension, can’t relax. I'm worried about running out of T early from loss, or somehow injecting less than my dose. A lot of sources say to, "draw to the line, loss is calculated ahead of time", etc. I have measured the extra test in the 18 guage needle when drawing and it measures to 0.06mL, which every day adds up. And how would I calculate this with regard to loss in the 25 guage injection needle after injecting?
Generally we don't have enough data to compare between the two, as you'd really need a man who has done both & testing multiple times with both at the same dosing and habits. Sometimes, the difference between "TRT is working" and "TRT feels great" comes down to getting the details right. When your levels are stable, your results tend to be stable.
You may report side effects to FDA at FDA-1088. This list may not describe all possible side effects. If you have diabetes, check with your care team before you change your diet or the dose of your diabetic medication. This medication may affect blood sugar levels. Get emergency help if you develop signs or symptoms of a heart attack or stroke.
It's not about changing your dose; it's about changing your injection frequency. And that E2 levels dont matter much when frequency and dosage are dialed in. Call your doctor for medical advice about side effects. Now I’m getting this overstimulated, wired feeling around 6–12h post-injection. What’s your preferred dosing frequency and why?
Decisions at this level should be made with a clinician who is monitoring labs at appropriate intervals (see cautions across the AUA guideline and dosing context in the Drugs.com monograph). Any androgen that lifts a person from deficient to physiologic levels may support improvements in lean mass and strength over time, especially when paired with progressive resistance training and adequate protein. Clinicians usually titrate to a mid-normal serum testosterone range while keeping safety labs in check. That’s the essence of a useful trt dosage chart—clear ranges, explicit timing, and built-in safety checkpoints. After 3–6 months, your team reviews symptoms and labs, then moves up or down in small increments. Charts should therefore include a note that dose is a tool to reach safe, therapeutic levels—not a target in itself—plus a reminder to monitor hematocrit, PSA, BP, and lipids on a schedule consistent with guidelines. Many stabilize in a mid-normal serum range using totals around ~75–150 mg/week for short-acting injectables, but outliers exist due to differences in absorption, SHBG, body size, and comorbidities.
But in many cases, the issue isn’t how much testosterone you’re taking, it’s how that dose is delivered over time. If your symptoms follow a pattern based on your injection timing, your frequency may need adjustment. If your labs are taken near a peak, they may look optimal, even if your levels drop significantly later in the week.
If you’re wondering how much trt should you take, your clinician will frame dose as a tool to reach a mid-normal physiologic range rather than a fixed target. When in doubt—especially with rapidly rising hematocrit, significant PSA changes, uncontrolled hypertension, or new cardiopulmonary symptoms—clinicians generally hold therapy and reassess before resuming at a lower dose or different schedule. Most clinicians titrate gradually, then reassess labs and symptoms after 3–6 months, following principles laid out in the Endocrine Society guideline. A widely cited consensus notes that the only evidence-based indication is HSDD in postmenopausal women and that dosing should keep blood levels within the female physiologic range (see the Global Consensus Position Statement, 2019). This prevents accidental over- or under-dosing and keeps labs interpretable.